1613321-11-1

Basic information

• Product Name: (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate
• Synonyms: (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate
• CAS NO: 1613321-11-1
• Molecular Weight: 1486.03
• Mol File: 1613321-11-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate(1613321-11-1)
• EPA Substance Registry System: (2S,3S,4R)-2-(N-((9H-fluoren-9-yl)methoxycarbonyl)-L-valinyl-L-citrullinyl-4-am inobenzyloxycarbonylamino)-1-(δ-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yl hexacosanoate(1613321-11-1)

Safety Data

• Hazardous Substances Data: 1613321-11-1(Hazardous Substances Data)

Upstream product

• 1541195-53-2 (2S,3S,4R)-2-amino-1-O-(α-D-galactopyranosyl)-4-O-(hexacosanoyl)octadecane-1,3,4-triol 
• 863971-53-3 (9H-fluoren-9-yl)methyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate 

Downstream Products

• 1613321-12-2 (2S,3S,4R)-2-(L-vaIinyl-L-citrullinyl-4-aminobenzyloxycarbonylamino)-1-(α-D-galactopyranosyloxy)-3-hydroxyoctadecan-4-yI hexacosanoate 

Relevant articles and documents

CANCER VACCINE

The invention relates to a combination of a TLR-9 agonist and a conjugate of Formula (I) or pharmaceutically acceptable salt thereof. (Formula (I))

CONJUGATE COMPOUNDS

The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.